|
⚲
|
| Keyboard |
| Haft Nicholas
✚
|
|
|---|---|
| CIK # | 0001850404 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001850404] | |
| 4 | [0001850404] | |
| SC 13D | [0001850404] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Haft Nicholas | Finch Therapeutics Group Inc | [2021-03-29] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Finch Therapeutics Group Inc | |
| Haft Nicholas |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Finch Therapeutics Group Inc FNCH
Stock Option (right to buy) · derivative
|
2023-06-08 | Grant | 10,000 | $0.00 | |
|
Finch Therapeutics Group Inc FNCH
Stock Option (right to buy) · derivative
|
2022-06-13 | Grant | 44,843 | $0.00 | |
|
Finch Therapeutics Group Inc FNCH
Common Stock, $0.001 par value per share
|
2021-12-20 | Buy | 63,850 | $10.18 | 649,993 |
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Conversion | 212,893 | ||
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Conversion | 1,064,466 | ||
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Buy | 882,351 | $17.00 | 14,999,967 |
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Conversion | 1,150,481 | ||
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Conversion | 143,831 | ||
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Conversion | 172,942 | ||
|
Finch Therapeutics Group Inc FNCH
Series D Preferred Stock · derivative
|
2021-03-23 | Conversion | 1,150,481 | $0.00 | |
|
Finch Therapeutics Group Inc FNCH
Series C Preferred Stock · derivative
|
2021-03-23 | Conversion | 212,893 | $0.00 | |
|
Finch Therapeutics Group Inc FNCH
Series C Preferred Stock · derivative
|
2021-03-23 | Conversion | 366,093 | $0.00 | |
|
Finch Therapeutics Group Inc FNCH
Series B Preferred Stock · derivative
|
2021-03-23 | Conversion | 1,064,466 | $0.00 | |
|
Finch Therapeutics Group Inc FNCH
Series A Preferred Stock · derivative
|
2021-03-23 | Conversion | 143,831 | $0.00 | |
|
Finch Therapeutics Group Inc FNCH
Series A Preferred Stock · derivative
|
2021-03-23 | Conversion | 172,942 | $0.00 | |
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Conversion | 366,093 |